NewcelX Ltd. (NCEL) stock
NCELNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 4/30
$2.54−0.15 (-5.58%)
Close on Nov 20, 2026Market cap $12.19MP/E 1.2Yield –
NewcelX operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -$2.77M. The highest annual figure on record is -$190.01K in fiscal 2019.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$2.77M | – |
| FY2024 | Dec 31, 2024 | -$1.07M | – |
| FY2023 | Dec 31, 2023 | -$3.44M | – |
| FY2022 | Dec 31, 2022 | -$13.88M | – |
| FY2021 | Dec 31, 2021 | -$14.94M | – |
| FY2020 | Dec 31, 2020 | -$729.39K | – |
| FY2019 | Dec 31, 2019 | -$190.01K | – |
| FY2018 | Dec 31, 2018 | -$2.73M | – |
See a number that looks wrong?